Abstract：Objective To investigate the effect of enteral nutrition on postoperative inflammatory reaction and prognosis in patients with gastrointestinal tumor. Methods 90 patients with gastrointestinal tumor in the Department of General Surgery in this hospital from April 2015 to February 2016 were recruited as the research objects. The patients were randomly divided into enteral nutrition intervention group (45 patients) and parenteral nutrition group (45 patients). Fasting venous blood in the morning of 1d before the operation, 1, 3, 9 d after the operation was collected, to test CRP, IL-6, TNF-α, and the prognoses of the patients were observed.Results There were significant differences in CRP, IL-6 and TNF-α between the two groups of patients with enteral nutrition and parenteral nutrition(Fgroup＝26.381, 17.574, 23.546, all P<0.05). CRP, IL-6 and TNF-α were significantly increased after 1d(all P<0.05), CRP, IL-6 3 d after operation were significantly reduced(all P<0.05), among them, only IL-6 9 d after operation recovered to preoperative 1 d level, TNF-α significantly decreased 9 d after operation, but it was still higher than preoperative 1 d level. The reduction of CRP, IL-6 and TNF-α in the enteral nutrition intervention group were higher than those in the parenteral nutrition group(Finteractive＝9.542, 6.876, 7.958, all P<0.05). In enteral nutrition intervention group, the recovery time of bowel sounds, first anal exhaust time, first anal defecation time, postoperative hospitalization days were significantly lower than those in the parenteral nutrition group and had significant differences(all P<0.05). The incidence of incision infection, pulmonary infection and urinary system infection in the intestinal nutrition intervention group were lower than those in the parenteral nutrition group and the differences were statistically significant(all P<0.05).Conclusions Enteral nutrition intervention can reduce postoperative inflammatory reaction and improve the prognosis of patients with gastrointestinal tumor.
Daniela T, Nelson S A, Bo-Hyun M,et al. High-energy particle-induced tumorigenesis throughout the gastrointestinal tract [J]. Radiat Res, 2014, 181(2): 162-171.
Schmidt S, Dunet V, Koehli M, et al. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT [J]. Acta Radiologica, 2013, 54(8): 837-842.
[4]
Liu Q, Liu Z, Chen H, et al. Treatment with growth hormone, somatostatin, and insulin in combination with hypocaloric parenteral nutrition in gastrointestinal cancer patients after surgery [J]. Nutrition, 2011, 27(6): 633-640.
[5]
Ma C J, Sun L C, Chen F M, et al. A double-blind randomized study comparing the efficacy and safety of a composite vs a conventional intravenous fat emulsion in postsurgical gastrointestinal tumor patients [J]. Nutr Clin Pract, 2012, 27(3): 410-415.
[6]
Regan K N, Shinagare A B, Saboo S S, et al. Gastrointestinal stromal tumors (GIST):lesser known facts[J]. Clin Imag, 2013, 37(5): 821-829.
Riedel M, Voit B. Synthesis of multifunctional polymers by combination of controlled radical polymerization (CRP) and effective polymer analogous reactions [J]. Pure Appl Chem, 2013, 85(3): 557-571.
[10]
Wang M S, Black J C, Knowles M K, et al. C-reactive protein (CRP) aptamer binds to monomeric but not pentameric form of CRP [J]. Anal Bioanal Chem, 2011, 401 (4): 1309-1318.
[11]
Soo K L, Hyun C K, Sang J C, et al. Binding behavior of CRP and anti-CRP antibody analyzed with SPR and AFM measurement [J]. Ultramicroscopy, 2008, 108(10):1374-1378.
[12]
Goergens S W, Eckardt K, Elsen M, et al. Chitinase-3-like protein 1 protects skeletal muscle from TNF alpha-induced inflammation and insulin resistance [J]. Biochem J, 2014, 459(3): 479-488.
[13]
Masuda K, Ripley B, Nishimura R, et al. Arid 5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo[J]. PNAS, 2013, 110(23): 9409-9414.
[14]
Galan M G, Drago S R. Food matrix and cooking process affect mineral bioaccessibility of enteral nutrition formulas [J]. J Sci Food Agricul, 2014,94(3):515-521.
[15]
Nagano T, Fujita H, Tanaka T, et al. A randomized controlled trial comparing antioxidant -enriched enteral nutrition with immune-enhancing enteral nutrition after esophagectomy for cancer: a pilot study [J]. Surg Today, 2013, 43(11): 1240-1249.
2016, Vol. 27 
